Publications: View by Years
Jump to: In Press | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 and older
You are viewing publications by year. Click here to return to see the full list of publications.
2011
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.
Genetics in medicine : official journal of the American College of Medical Genetics. 13(6), 597-605. Abstract
(2011).
Personalized oncology through integrative high-throughput sequencing: a pilot study.
Science translational medicine. 3(111), 111ra121. Abstract
(2011).
Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.
Genetics in medicine : official journal of the American College of Medical Genetics. Abstract
(2011).
Modeling decisions to undergo genetic testing for susceptibility to common health conditions: an ancillary study of the Multiplex Initiative.
Psychology & Health. 27(4), 430-44. Abstract
(2011).
Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs.
Genetics in medicine : official journal of the American College of Medical Genetics. 13(4), 325-32. Abstract
(2011).
Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
(2011).
Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.
Genetic testing and molecular biomarkers. 15(12), 871-5. Abstract
(2011).
(2011).
2010
Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members.
Neurology. 75(5), 425-31. Abstract
(2010).
Genetic testing for Alzheimer's and long-term care insurance.
Health affairs (Project Hope). 29(1), 102-8. Abstract
(2010).
Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.
The American journal of clinical nutrition. 91(5), 1402-7. Abstract
(2010).
Successful aging in the United States: prevalence estimates from a national sample of older adults..
The journals of gerontology. Series B, Psychological sciences and social sciences. 65B(2), 216-26. Abstract
(2010).
Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions..
Future neurology. 5(4), 501-517. Abstract
(2010).
Returning individual research results: development of a cancer genetics education and risk communication protocol.
Journal of empirical research on human research ethics : JERHRE. 5(3), 17-30. Abstract
(2010).
The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study.
European journal of human genetics : EJHG. 18(12), 1296-301. Abstract
(2010).
"I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.
Genetics in medicine : official journal of the American College of Medical Genetics. 12(4), 219-27. Abstract
Download: PDF (310.84 KB)
(2010).
Understandings of basic genetics in the United States: results from a national survey of black and white men and women.
Public health genomics. 13(7-8), 467-76. Abstract
(2010). 2009
A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease.
Alzheimer disease and associated disorders. 23(1), 50-6. Abstract
(2009).
Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.
Journal of health communication. 14(8), 768-84. Abstract
(2009).